Review



c18 unsaturated fa against multi drug resistant bacteria  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC c18 unsaturated fa against multi drug resistant bacteria
    Antibacterial activity of the <t> C18 unsaturated FA against multi-drug resistant bacteria </t> a
    C18 Unsaturated Fa Against Multi Drug Resistant Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 22300 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c18+unsaturated+fa+against+multi+drug+resistant+bacteria/Bacteria/pmc05513723-505-22-56
    Average 99 stars, based on 22300 article reviews
    c18 unsaturated fa against multi drug resistant bacteria - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli"

    Article Title: 2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli

    Journal: Lipids

    doi: 10.1007/s11745-017-4262-1

    Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a
    Figure Legend Snippet: Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a

    Techniques Used: Activity Assay

    Related Articles

    Activity Assay:

    Article Title: 2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli
    Article Snippet: .. MRSA = Methicillin-resistant S. aureus ; ClMRSA = Clinical isolates of MRSA; SEM =Standard error of the mean Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a table ft1 table-wrap mode="anchored" t5 caption a7 Microoorganisms MIC/IC 50 SEM, µg/mL Fatty acids (±)-( 3 ) (±)-( 1 ) 2-methoxy-16:0 b 6-hexadecynoic acid S. aureus (ATCC 29213) 62.5/37.9 ± 0.4 62.5/35.4 ± 0.3 250/92.9 ± 4.0 125/68.1 ± 4.5 E. coli (ATCC 25922) 250/140.8 ± 4.0 62.5/21.2 ± 0.6 > 1000 > 1000 ClMRSA I 250/151.3 ± 1.3 62.5/31.3 ± 0.5 250/155.5 ± 15.2 125/65.1 ± 3.4 ClMRSA II 250/121.5 ± 5.8 125/80.6 ± 4.3 ND 62.5/43.0 ± 0.7 MRSA (ATCC 43300) 62.5/38.2 ± 2.0 62.5/30.0 ± 0.9 250/146.1 ± 0.7 250/160.6 ± 1.7 ClMRSA IX 500/297.6 ± 1.0 125/77.5 ± 1.5 250/100.4 ± 4.3 125/58.0 ± 1.2 Open in a separate window a Experiments were performed in triplicate ( n = 3). .. Microoorganisms MIC/IC 50 SEM, μg/mL Fatty acids (±)-( 3 ) (±)-( 1 ) 2-methoxy-16:0 b 6-hexadecynoic acid S. aureus (ATCC 29213) 62.5/37.9 ± 0.4 62.5/35.4 ± 0.3 250/92.9 ± 4.0 125/68.1 ± 4.5 E. coli (ATCC 25922) 250/140.8 ± 4.0 62.5/21.2 ± 0.6 > 1000 > 1000 ClMRSA I 250/151.3 ± 1.3 62.5/31.3 ± 0.5 250/155.5 ± 15.2 125/65.1 ± 3.4 ClMRSA II 250/121.5 ± 5.8 125/80.6 ± 4.3 ND 62.5/43.0 ± 0.7 MRSA (ATCC 43300) 62.5/38.2 ± 2.0 62.5/30.0 ± 0.9 250/146.1 ± 0.7 250/160.6 ± 1.7 ClMRSA IX 500/297.6 ± 1.0 125/77.5 ± 1.5 250/100.4 ± 4.3 125/58.0 ± 1.2 Open in a separate window a Experiments were performed in triplicate ( n = 3).

    Bacteria:

    Article Title: 2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli
    Article Snippet: .. MRSA = Methicillin-resistant S. aureus ; ClMRSA = Clinical isolates of MRSA; SEM =Standard error of the mean Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a table ft1 table-wrap mode="anchored" t5 caption a7 Microoorganisms MIC/IC 50 SEM, µg/mL Fatty acids (±)-( 3 ) (±)-( 1 ) 2-methoxy-16:0 b 6-hexadecynoic acid S. aureus (ATCC 29213) 62.5/37.9 ± 0.4 62.5/35.4 ± 0.3 250/92.9 ± 4.0 125/68.1 ± 4.5 E. coli (ATCC 25922) 250/140.8 ± 4.0 62.5/21.2 ± 0.6 > 1000 > 1000 ClMRSA I 250/151.3 ± 1.3 62.5/31.3 ± 0.5 250/155.5 ± 15.2 125/65.1 ± 3.4 ClMRSA II 250/121.5 ± 5.8 125/80.6 ± 4.3 ND 62.5/43.0 ± 0.7 MRSA (ATCC 43300) 62.5/38.2 ± 2.0 62.5/30.0 ± 0.9 250/146.1 ± 0.7 250/160.6 ± 1.7 ClMRSA IX 500/297.6 ± 1.0 125/77.5 ± 1.5 250/100.4 ± 4.3 125/58.0 ± 1.2 Open in a separate window a Experiments were performed in triplicate ( n = 3). .. Microoorganisms MIC/IC 50 SEM, μg/mL Fatty acids (±)-( 3 ) (±)-( 1 ) 2-methoxy-16:0 b 6-hexadecynoic acid S. aureus (ATCC 29213) 62.5/37.9 ± 0.4 62.5/35.4 ± 0.3 250/92.9 ± 4.0 125/68.1 ± 4.5 E. coli (ATCC 25922) 250/140.8 ± 4.0 62.5/21.2 ± 0.6 > 1000 > 1000 ClMRSA I 250/151.3 ± 1.3 62.5/31.3 ± 0.5 250/155.5 ± 15.2 125/65.1 ± 3.4 ClMRSA II 250/121.5 ± 5.8 125/80.6 ± 4.3 ND 62.5/43.0 ± 0.7 MRSA (ATCC 43300) 62.5/38.2 ± 2.0 62.5/30.0 ± 0.9 250/146.1 ± 0.7 250/160.6 ± 1.7 ClMRSA IX 500/297.6 ± 1.0 125/77.5 ± 1.5 250/100.4 ± 4.3 125/58.0 ± 1.2 Open in a separate window a Experiments were performed in triplicate ( n = 3).



    Similar Products

    c18 unsaturated fa against multi drug resistant bacteria  (ATCC)
    99
    ATCC c18 unsaturated fa against multi drug resistant bacteria
    Antibacterial activity of the <t> C18 unsaturated FA against multi-drug resistant bacteria </t> a
    C18 Unsaturated Fa Against Multi Drug Resistant Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c18+unsaturated+fa+against+multi+drug+resistant+bacteria/Bacteria/pmc05513723-505-22-56
    Average 99 stars, based on 1 article reviews
    c18 unsaturated fa against multi drug resistant bacteria - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a

    Journal: Lipids

    Article Title: 2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli

    doi: 10.1007/s11745-017-4262-1

    Figure Lengend Snippet: Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a

    Article Snippet: MRSA = Methicillin-resistant S. aureus ; ClMRSA = Clinical isolates of MRSA; SEM =Standard error of the mean Antibacterial activity of the C18 unsaturated FA against multi-drug resistant bacteria a table ft1 table-wrap mode="anchored" t5 caption a7 Microoorganisms MIC/IC 50 SEM, µg/mL Fatty acids (±)-( 3 ) (±)-( 1 ) 2-methoxy-16:0 b 6-hexadecynoic acid S. aureus (ATCC 29213) 62.5/37.9 ± 0.4 62.5/35.4 ± 0.3 250/92.9 ± 4.0 125/68.1 ± 4.5 E. coli (ATCC 25922) 250/140.8 ± 4.0 62.5/21.2 ± 0.6 > 1000 > 1000 ClMRSA I 250/151.3 ± 1.3 62.5/31.3 ± 0.5 250/155.5 ± 15.2 125/65.1 ± 3.4 ClMRSA II 250/121.5 ± 5.8 125/80.6 ± 4.3 ND 62.5/43.0 ± 0.7 MRSA (ATCC 43300) 62.5/38.2 ± 2.0 62.5/30.0 ± 0.9 250/146.1 ± 0.7 250/160.6 ± 1.7 ClMRSA IX 500/297.6 ± 1.0 125/77.5 ± 1.5 250/100.4 ± 4.3 125/58.0 ± 1.2 Open in a separate window a Experiments were performed in triplicate ( n = 3).

    Techniques: Activity Assay